Teller assessment test sample

Post here and/or PM me with any questions. Shipping is $5. International is available, please discuss. Free samples with every purchase! Payment is by Venmo, CashApp or Zelle, PayPal must inquire.
Only swapping for 200mL Baccarat Rouge 540 Extrait and Louis Vuitton Symphony at this time.
All of my contact info as well as all of my bottles for sale, are available in my spreadsheet which you should bookmark and look at for a more updated inventory
Spreadsheet

	HOUSE	FRAGRANCE	SIZE	REMAINING	Notes/Condition	Price	Type
1	Amouage	Amber Sogara	12mL	100% Full	Brand New, Sealed	$335	Niche
2	Amouage	Incense Rori Attar	12mL	100% Full	Brand New, Sealed	$299	Niche
3	Amouage	Orris Wakan Attar	12mL	99% Full	Full Presentation	$299	Niche
4	Amouage	Rose Aqor Attar	12mL	99% Full	Full Presentation	$299	Niche
5	Amouage	Saffron Hamra Attar	12mL	100% Full	Brand New, Sealed	$299	Niche
6	Andy Tauer	Cologne du Maghreb	50mL	99% Full	First Release, Rectangular Clear Bottle; With box	$95	Niche
7	Bond No. 9	Central Park West	100mL	100% Full	Tester (No Box or Cap)	$149	Niche
8	Bond No. 9	Dubai Jade	100mL	100% Full	Tester with Cap (No Box)	$200	Niche
9	Bond No. 9	Hamptons	100mL	100% Full	Tester (No Box or Cap)	$149	Niche
10	Bond No. 9	Madison Square Park	100mL	100% Full	Tester (No Box or Cap)	$149	Niche
11	Bond No. 9	NOMAD	100mL	100% Full	Tester (No Box or Cap)	$169	Niche
12	Bond No. 9	Riverside Drive	100mL	100% Full	Tester (No Box or Cap)	$149	Niche
13	Bond No. 9	So New York	100mL	100% Full	Tester (No Box or Cap)	$149	Niche
14	Bond No. 9	Sutton Place	100mL	100% Full	Tester (No Box or Cap)	$149	Niche
15	Bond No. 9	Wall Street	100mL	100% Full	Tester (No Box or Cap)	$149	Niche
16	By Kilian	Bamboo Harmony	100mL	100% Full	Tester Refill (No Spray, No Box)	$199	Niche
17	By Kilian	Black Phantom	100mL	100% Full	Tester Refill (No Spray, No Box)	$199	Niche
18	By Kilian	Can't Stop Loving You	50mL	100% Full	Brand New, Sealed	$185	Niche
19	By Kilian	Forbidden Games	50mL	98% Full	Tester Refill (No Spray, No Box)	$125	Niche
20	By Kilian	Gold Knight	100mL	100% Full	Tester Refill (No Spray, No Box)	$199	Niche
21	By Kilian	Gold Knight	50mL	98% Full	Tester Refill (No Spray, No Box)	$145	Niche
22	By Kilian	Good Girl Gone Bad	250mL	99% Full	Decanter; No Box	$650	Niche
23	By Kilian	Good Girl Gone Bad	50mL	98% Full	Tester Refill (No Spray, No Box)	$135	Niche
24	By Kilian	Good Girl Gone Bad Eau Fraiche	50mL	100% Full	Brand New, Sealed	$180	Niche
25	By Kilian	Intoxicated	100mL	100% Full	Tester Refill (No Spray, No Box)	$199	Niche
26	By Kilian	L'Heure Verte	50mL	100% Full	Brand New, Sealed	$135	Niche
27	By Kilian	Moonlight In Heaven	100mL	99% Full	Tester Refill (No Spray, No Box)	$199	Niche
28	By Kilian	Roses on Ice	50mL	100% Full	Brand New, Sealed	$135	Niche
29	Byredo	Eyes Closed	50mL	100% Full	Brand New, Sealed	$135	Niche
30	Byredo	Infloresence	100mL	100% Full	Tester; No Box	$135	Niche
31	Byredo	Lil Fleur	100mL	100% Full	Tester; No Box	$135	Niche
32	Byredo	Sunday Cologne	100mL	100% Full	Tester; No Box	$135	Niche
33	Chanel / Chanel Exclusif	Beige Parfum	15mL	100% Full	Tester with Cap (No Box)	$180	Niche
34	Chanel / Chanel Exclusif	Misia EdT	200mL	90% Full	Tester with Cap (No Box)	$325	Niche
35	Chanel / Chanel Exclusif	No. 22 EdT	200mL	95% Full	Tester with Cap (No Box)	$325	Niche
36	Christian Dior / Dior Privee	7 Mini Set as Pictured	7x 5mL	100% Full	7 Official Minis from 2010-2011... Mitzah, Milly-A-La-Foret, Granville, Cologne Royale, Eau Noire, New Look 1947	$180	Niche
37	Christian Dior / Dior Privee	Bois D'Argent	5mL	100% Full	Official Mini - Batch Code 0V01 (2010 Production Date) - Price includes shipping	$35	Niche
38	Christian Dior / Dior Privee	Cologne Royale	5mL	100% Full	Official Mini - Batch Code 1X01 (2011 Production Date) - Price includes shipping	$30	Niche
39	Christian Dior / Dior Privee	Diorissima	7.5mL	100% Full	Official Mini; No Cannister - Price includes shipping	$30	Niche
40	Christian Dior / Dior Privee	Eau Noire	5mL	100% Full	Official Mini - Batch Code 1R01 (2011 Production Date) - Price includes shipping	$35	Niche
41	Christian Dior / Dior Privee	Eden Roc	7.5mL	100% Full	Official Mini - Price includes shipping	$30	Niche
42	Christian Dior / Dior Privee	Granville	5mL	100% Full	Official Mini - Batch Code 0V01 (2010 Production Date) - Price includes shipping	$35	Niche
43	Christian Dior / Dior Privee	Milly-La-Foret	5mL	100% Full	Official Mini - Batch Code 0W01 (2010 Production Date) - Price includes shipping	$30	Niche
44	Christian Dior / Dior Privee	New Look 1947	5mL	100% Full	Official Mini - Batch Code 1R01 (2011 Production Date) - Price includes shipping	$30	Niche
45	Clive Christian	C for Men	50mL	95% Full	Tester (No Box)	$169	Niche
46	Clive Christian	I Pour Femme (Woody Floral with Vintage Rose)	50mL	99% Full	Tester (No Box)	$169	Niche
47	Clive Christian	Rock Rose	50mL	100% Full	Tester (No Box)	$229	Niche
48	Clive Christian	X Pour Femme	50mL	100% Full	Tester (No Box)	$169	Niche
49	Creed	Aventus - 19P21 (Decant)	50mL	100% Full	Magnetic Cap Decant	$169	Niche
50	Creed	Aventus - F1396	100mL	100% Full	Tester (No Box)	$209	Niche
51	Creed	Aventus for Her - F Batch	75mL	100% Full	Tester with Plastic Cap (No Box)	$175	Niche
52	Creed	Bois du Portugal	100mL	100% Full	Tester (No Box)	$185	Niche
53	Creed	Carmina - F1449	75mL	100% Full	Tester (No Cap or Box)	$199	Niche
54	Creed	Erolfa	100mL	100% Full	Tester with Plastic Cap	$185	Niche
55	Creed	Green Irish Tweed	100mL	100% Full	Tester with Plastic Cap (No Box)	$195	Niche
56	Creed	Himalaya - F Batch	100mL	100% Full	Tester with Plastic Cap (No Box)	$185	Niche
57	Creed	Jardin D'Amalfi	75mL	100% Full	Tester (No Box, No Cap)	$199	Niche
58	Creed	Millesime Imperial	100mL	100% Full	Tester with Plastic Cap (No Box)	$185	Niche
59	Creed	Original Santal	100mL	100% Full	Tester with Plastic Cap (No Box)	$185	Niche
60	Creed	Original Vetiver	100mL	100% Full	Tester with Plastic Cap (No Box)	$185	Niche
61	Creed	Queen of Silk	75mL	100% Full	Tester with Metal Cap	$275	Niche
62	Creed	Refillable Atomizer (5mL Leather Wrapped) Blue	5mL	100% Full	Brand New, Sealed	$85	Niche
63	Creed	Refillable Atomizer (5mL Leather Wrapped) Grey	5mL	100% Full	Brand New, Sealed	$85	Niche
64	Creed	Royal Oud - F Batch	100mL	100% Full	Tester with Plastic Cap (No Box)	$260	Niche
65	Creed	Royal Water - F238	100mL	100% Full	Tester with Plastic Cap (No Box)	$180	Niche
66	Creed	Silver Mountain Water - 21V01A	100mL	100% Full	Tester with Plastic Cap (No Box)	$180	Niche
67	Creed	Spice and Wood	75mL	100% Full	Tester (No Box)	$219	Niche
68	Creed	Viking - F BATCH	100mL	100% Full	Tester with Plastic Cap (No Box)	$190	Niche
69	Creed	Viking Cologne	100mL	100% Full	Tester with Plastic Cap	$185	Niche
70	Creed	Virgin Island Water	100mL	100% Full	Tester with Plastic Cap (No Box)	$195	Niche
71	Creed	White Amber - 17R01	75mL	100% Full	Tester (No Box or Cap)	$155	Niche
72	Diptyque	Eau de Papier EdT	100mL	100% Full	Tester with Cap	$100	Niche
73	Diptyque	Ombre Dans L'eau EdT	100mL	100% Full	Tester with Cap	$100	Niche
74	Diptyque	Oyedo EdT	100mL	100% Full	Tester (No Box)	$100	Niche
75	Diptyque	Philosykos EdT	100mL	100% Full	Tester (No Box)	$100	Niche
76	Fragrance Du Bois	Brume du Matin	100mL	100% Full	New, No Box	$180	Niche
77	Fragrance Du Bois	Cannabis Blue	100mL	100% Full	New, No Box	$180	Niche
78	Fragrance Du Bois	Cannabis Intense	100mL	100% Full	New, No Box	$180	Niche
79	Fragrance Du Bois	HERITAGE	100mL	100% Full	New, No Box	$330	Niche
80	Fragrance du Bois	Lovers	100mL	100% Full	Brand New, Sealed	$325	Niche
81	Fragrance Du Bois	New York Fifth Avenue	100mL	100% Full	New, No Box	$180	Niche
82	Fragrance Du Bois	SAHRAA	100mL	99% Full	Full presentation with Box	$399	Niche
83	Fragrance Du Bois	Siberian Rose	100mL	100% Full	New, No Box	$180	Niche
84	Frederic Malle	Cologne Indellible	100mL	85% Full	Full presentation with Box	$175	Niche
85	Frederic Malle	Eau de Magnolia	10mL	100% Full	Official Travel Spray	$55	Niche
86	Frederic Malle	Monsieur	10mL	95% Full	Official Travel Spray	$55	Niche
87	Frederic Malle	Promise	100mL	100% Full	Brand New (Not Sealed)	$315	Niche
88	Gallagher	Bergamot Silk	100mL	99% Full	No Box	$79	Niche
89	Giorgio Armani / Armani Prive	Pierre de Lune	100mL	100% Full	Tester; No Box	$155	Niche
90	Giorgio Armani / Armani Prive	Rose Alexandrie	100mL	100% Full	Tester; No Box	$155	Niche
91	Guerlain	Angelique Noire	30mL	100% Full	Mini Bee Bottle Decant	$215	Niche
92	Guerlain	Angelique Noire	10mL	100% Full	Tall Glass Decant	$55	Niche
93	Guerlain	French Kiss	75mL	98% Full	Tester (No Box or Cap)	$450	Niche
94	Guerlain	Frenchy Lavende	200mL	100% Full	Brand New, Sealed	$399	Niche
95	Guerlain	Herbes Troublantes	200mL	100% Full	Tester (No Box)	$339	Niche
96	Guerlain	Jasmin Bonheur	200mL	100% Full	Tester (No Box)	$369	Niche
97	Guerlain	Neroli Outrenoir	200mL	100% Full	Tester (No Box)	$339	Niche
98	Guerlain	Spiriteuse Double Vanille	200mL	100% Full	Tester with Cap	$399	Niche
99	Guerlain	Tobacco Honey	200mL	100% Full	Brand New, Sealed	$399	Niche
100	Hermes / Hermessence	Agar Ebene	100mL	100% Full	Tester (No Box or Cap)	$150	Niche
101	Hermes / Hermessence	Ambre Narguile	100mL	100% Full	Tester (No Box)	$175	Niche
102	Hermes / Hermessence	Cedre Sambac	100mL	100% Full	Tester (No Box)	$165	Niche
103	Hermes / Hermessence	Epice Marine	100mL	100% Full	Tester (No Box)	$170	Niche
104	Hermes / Hermessence	Myrrhe Eglantine	100mL	100% Full	Tester (No Box)	$185	Niche
105	Hermes / Hermessence	Poivre Samarcade	100mL	100% Full	Tester (No Box)	$170	Niche
106	Hermes / Hermessence	Santal Massoia	100mL	100% Full	Tester (No Box)	$170	Niche
107	Hermes / Hermessence	Vetiver Tonka	100mL	100% Full	Tester (No Box)	$175	Niche
108	House of Sillage	Nouez Moi	75mL	99% Full	Tester (No Box or Cap)	$120	Niche
109	I Profumi di Firenze	Caterina De Medici	50mL	99% Full	No Box	$35	Niche
110	Initio	High Frequency	90mL	100% Full	Tester (No Box)	$180	Niche
111	Initio	Oud for Happiness	90mL	100% Full	Tester; No Box	$189	Niche
112	Jo Malone	English Pear & Freesia	30mL	100% Full	No Box	$50	Niche
113	Le Labo	Bigarade 18 - Hong Kong Exclusive	50mL	100% Full	Full Bottle, Retail Label	$299	Niche
114	Le Labo	Mousse de Chene 30 - Amsterdam City Exclusive	50mL	99% Full	Sprayed Once to Test / Brand New; No Box	$259	Niche
115	Le Labo	Oud 27	50mL	99% Full	Full presentation with Box	$169	Niche
116	Le Labo	Santal 33	50mL	100% Full	Full Bottle, Retail Label	$135	Niche
117	Liquides Imaginaires	Bloody Wood	100mL	100% Full	Tester; No Box, No Cap	$85	Niche
118	Liquides Imaginaires	Desert Sauve	100mL	99% Full	Tester; No Box, No Cap	$85	Niche
119	Liquides Imaginaires	Fleur de Sable	100mL	99% Full	Tester; No Box, No Cap	$85	Niche
120	Liquides Imaginaires	Fleuve Tendre	100mL	100% Full	Tester; No Box, No Cap	$85	Niche
121	Liquides Imaginaires	Sancti	100mL	100% Full	Tester; No Box, No Cap	$85	Niche
122	Loewe	7 EdT	100mL	100% Full	Tester (No Box)	$90	Niche
123	Loewe	Aire Anthesis	100mL	100% Full	Tester (No Box)	$100	Niche
124	Loewe	Esencia EdP	100mL	100% Full	Tester (No Box)	$120	Niche
125	Loewe	Esencia Elixir	100mL	100% Full	Tester (No Box)	$200	Niche
126	Loewe	Man 001 EdP	100mL	100% Full	Tester (No Box)	$120	Niche
127	Louis Vuitton	Contre Moi	100mL	99% Full	Tester (Bottle may show some damage, Cap has no paint/is peeling)	$385	Niche
128	Louis Vuitton	Sun Song	100mL	98% Full	Tester (Bottle is scratched, may have an engraving, and Cap has no paint/is peeling)	$425	Niche
129	Louis Vuitton	Sun Song	200mL	98% Full	Dummy Bottle, filled with real juice. I don't think it's refillable.	$750	Niche
130	Maison Crivelli	Bois Datchai	100mL	100% Full	Brand New, Sealed	$169	Niche
131	Maison Francis Kurkdjian	724	200mL	100% Full	Tester with Cap (No Box)	$355	Niche
132	Maison Francis Kurkdjian	724	70mL	100% Full	Tester with Cap (No Box)	$165	Niche
133	Maison Francis Kurkdjian	A la Rose	200mL	100% Full	Tester with Cap (No Box)	$315	Niche
134	Maison Francis Kurkdjian	Amyris Femme EdP	70mL	100% Full	Tester (No Box)	$150	Niche
135	Maison Francis Kurkdjian	Amyris Femme Extrait	70mL	100% Full	Tester with Cap (No Box)	$160	Niche
136	Maison Francis Kurkdjian	Amyris Homme EdT	70mL	100% Full	Tester (No Box)	$160	Niche
137	Maison Francis Kurkdjian	Aqua Celestia	70mL	100% Full	Tester with Cap (No Box)	$135	Niche
138	Maison Francis Kurkdjian	Aqua Celestia Cologne Forte	70mL	100% Full	Tester with Cap (No Box)	$145	Niche
139	Maison Francis Kurkdjian	Aqua Celestia Forte	70mL	100% Full	Tester with Cap (No Box)	$160	Niche
140	Maison Francis Kurkdjian	Aqua Media Cologne Forte	70mL	100% Full	Tester with Cap (No Box)	$150	Niche
141	Maison Francis Kurkdjian	Aqua Universalis	70mL	100% Full	Tester with Cap (No Box)	$135	Niche
142	Maison Francis Kurkdjian	Aqua Universalis Cologne Forte	70mL	100% Full	Tester with Cap (No Box)	$125	Niche
143	Maison Francis Kurkdjian	Aqua Universalis Cologne Forte	200mL	100% Full	Tester with Cap (No Box)	$225	Niche
144	Maison Francis Kurkdjian	Aqua Universalis Cologne Forte	35mL	100% Full	Tester with Cap (No Box)	$90	Niche
145	Maison Francis Kurkdjian	Aqua Universalis Forte	70mL	100% Full	Tester with Cap (No Box)	$160	Niche
146	Maison Francis Kurkdjian	Aqua Vitae	200mL	100% Full	Tester with Cap (No Box)	$215	Niche
147	Maison Francis Kurkdjian	Aqua Vitae	70mL	100% Full	Tester with Cap (No Box)	$135	Niche
148	Maison Francis Kurkdjian	Aqua Vitae Cologne Forte	70mL	100% Full	Tester with Cap (No Box)	$125	Niche
149	Maison Francis Kurkdjian	Aqua Vitae Forte	70mL	100% Full	Tester with Cap (No Box)	$160	Niche
150	Maison Francis Kurkdjian	Baccarat Rouge 540 EdP	70mL	100% Full	Tester with Cap (No Box)	$209	Niche
151	Maison Francis Kurkdjian	Baccarat Rouge 540 Extrait	70mL	100% Full	Tester with Cap (No Box)	$300	Niche
152	Maison Francis Kurkdjian	Feminine Pluriel	200mL	100% Full	Tester with Cap (No Box)	$335	Niche
153	Maison Francis Kurkdjian	Feminine Pluriel Special Edition Extrait	70mL	100% Full	Full Presentation With Mirror Display	$499	Niche
154	Maison Francis Kurkdjian	Gentle Fluidity Gold	200mL	100% Full	Brand New, Sealed	$365	Niche
155	Maison Francis Kurkdjian	Gentle Fluidity Gold	70mL	100% Full	Tester with Cap (No Box)	$165	Niche
156	Maison Francis Kurkdjian	L'eau a La Rose	35mL	100% Full	Tester with Cap (No Box)	$90	Niche
157	Maison Francis Kurkdjian	L'Homme a la Rose	70mL	100% Full	Tester with Cap (No Box)	$165	Niche
158	Maison Francis Kurkdjian	Masculin Pluriel	70mL	100% Full	Tester with Cap (No Box)	$165	Niche
159	Maison Francis Kurkdjian	Oud EdP	70mL	100% Full	Tester with Cap (No Box)	$170	Niche
160	Maison Francis Kurkdjian	Oud Extrait	70mL	100% Full	Tester with Cap (No Box)	$190	Niche
161	Maison Francis Kurkdjian	Oud Silk Mood EdP	70mL	100% Full	Tester with Cap (No Box)	$170	Niche
162	Maison Francis Kurkdjian	Oud Silk Mood Extrait	70mL	100% Full	Tester with Cap (No Box)	$190	Niche
163	Maison Francis Kurkdjian	Petit Matin	70mL	100% Full	Tester with Cap (No Box)	$145	Niche
164	Maison Lancome	Orange Bigarades	100mL	100% Full	Full presentation with Box	$229	Niche
165	Mark Birley	Charles Street	75mL	97% Full	Travel Version	$90	Niche
166	Memo Paris	French Leather	75mL	100% Full	Tester (No Box or Cap)	$115	Niche
167	Memo Paris	Italian Leather	75mL	100% Full	Tester (No Box or Cap)	$115	Niche
168	Memo Paris	Lailabella	75mL	100% Full	Tester (No Box or Cap)	$115	Niche
169	Memo Paris	Marfa	75mL	100% Full	Tester (No Box or Cap)	$115	Niche
170	Memo Paris	Moon Fever	75mL	100% Full	Tester (No Box or Cap)	$115	Niche
171	Memo Paris	Oriental Leather	75mL	100% Full	Tester (No Box or Cap)	$115	Niche
172	Mind Games	As-Suli's Diamond	100mL	100% Full	Brand New, Sealed	$249	Niche
173	Mind Games	Gardez	100mL	100% Full	Brand New, Sealed	$249	Niche
174	Mind Games	Vieri	100mL	100% Full	Brand New, Sealed	$249	Niche
175	Mizensir	Bois de Mysore	100mL	100% Full	Tester (No Box)	$155	Niche
176	Mizensir	Cologne de Matte	100mL	100% Full	Tester (No Box)	$155	Niche
177	Mizensir	Ideal Oud	100mL	100% Full	Tester (No Box)	$155	Niche
178	Mizensir	Rose Exaltante	100mL	100% Full	Tester (No Box)	$155	Niche
179	Mizensir	Tonic Water	100mL	100% Full	Tester (No Box)	$155	Niche
180	Mizensir	Vert Empire	100mL	100% Full	Tester (No Box)	$155	Niche
181	Oh Mon Dieu!	L'objet	100mL	100% Full	Full presentation with Box	$125	Niche
182	Oliver and Co.	M.O.U.S.S.E.	50mL	99% Full	Limited Edition 87/133	$110	Niche
183	Parfums de Marley	Valaya	75mL	100% Full	Tester with Cap (No Box)	$175	Niche
184	Penhaligon's	Elixir	100mL	90% Full	No Box	$250	Niche
185	Penhaligon's	Petra	100mL	100% Full	Tester (No Box)	$200	Niche
186	Penhaligon's	Cairo	100mL	100% Full	Brand New, Sealed	$220	Niche
187	Pomare's Stolen Perfume	Angel's Share	9mL	70% Full	No Box	$40	Niche
188	Precious Liquid	Iced Juniper	75mL	95% Full	Full presentation with Box (Limited Edition)	$135	Niche
189	Roja Dove	Creation-E Essence de Parfum	100mL	100% Full	Tester; No Box	$165	Niche
190	Roja Dove	Danger Pour Femme	50mL	100% Full	99% Full with Box	$275	Niche
191	Roja Dove	Elixir	100mL	100% Full	Brand New, Sealed	$175	Niche
192	Roja Dove	Elixir Essence Pour Femme	100mL	100% Full	No Box	$175	Niche
193	Roja Dove	Qatar	50mL	99% Full	Full Presentation	$339	Niche
194	Roja Dove	Scandal Essence de Parfum	100mL	100% Full	Tester; No Box	$165	Niche
195	Roja Dove	United Arab Emirates (UAE)	50mL	100% Full	Brand New, Sealed	$300	Niche
196	Roman Monegal	L'eau de Rose	50mL	97% Full		$70	Niche
197	Santa Maria Novella	Sandalo	100mL	95% Full	No Box	$80	Niche
198	Sospiro	Deep Amber Ocean	100mL	100% Full	Brand New, No Box	$170	Niche
199	Sospiro	Deep Amber Ocean	100mL	100% Full	Brand New, Sealed	$180	Niche
200	Spirit of Dubai	Bahar	50mL	100% Full	Tester with Cap and Travel Case	$175	Niche
201	Spirit of Dubai	Rimal	50mL	100% Full	Tester with Cap and Travel Case	$175	Niche
202	Tiziana Terenzi	Attar Cas	13mL	100% Full	Tester (No Box)	$225	Niche
203	Tiziana Terenzi	Chiron	100mL	100% Full	Tester (No Box)	$165	Niche
204	Tiziana Terenzi	Draconis	100mL	100% Full	Tester (No Box)	$135	Niche
205	Tom Ford	Azure Lime - A71	50mL	99% Full	Original Formula	$349	Niche
206	Tom Ford	Beau de Jour	1000mL	100% Full	Sealed Dramming Bottle	$700	Niche
207	Tom Ford	Ebene Fume	50mL	100% Full	Brand New, Sealed	$165	Niche
208	Tom Ford	Electric Cherry	50mL	100% Full	Brand New, Sealed	$200	Niche
209	Tom Ford	Fleur de Portofino	50mL	100% Full	Brand New, Sealed	$135	Niche
210	Tom Ford	Fougere Platine	1000mL	100% Full	Sealed Dramming Bottle	$700	Niche
211	Tom Ford	Neroli Portofino	50mL	100% Full	Brand New, Sealed	$140	Niche
212	Tom Ford	Plum Japonais	50mL	100% Full	Decant (No Box)	$215	Niche
213	Tom Ford	Rive Ambre - A63	50mL	99% Full	Original Formula	$225	Niche
214	Tom Ford	Rose de Amalfi	50mL	100% Full	Brand New, Sealed	$135	Niche
215	Tom Ford	Santal Blush	50mL	100% Full	Brand New, Sealed	$140	Niche
216	Tom Ford	Soleil Neige	1000mL	100% Full	Sealed Dramming Bottle	$700	Niche
217	Tom Ford	Tobacco Vanille	100mL	100% Full	Brand New, Sealed	$245	Niche
218	Tom Ford	Tubereuse Nue	50mL	100% Full	Brand New, Sealed	$150	Niche
219	Tom Ford	Vanille Fatale	50mL	100% Full	Brand New, Sealed	$180	Niche
220	Tom Ford	White Suede	1000mL	100% Full	Sealed Dramming Bottle	$700	Niche
221	Washington Tremlett	Black Tie	100mL	95% Full		$125	Niche
222	Widian	II Black	50mL	99% Full	Tester (No Box)	$149	Niche
223	Yves Saint Laurent	Babycat	125mL	100% Full	Brand New, Sealed	$300	Niche
224	Acqua di Parma	Magnolia Nobile	100mL	100% Full	Tester (No Box)	$95	Designer
225	Brunello Cucinelli	Pour Homme	100mL	100% Full	Tester (No Box)	$90	Designer
226	Caron	Pour un Homme de Caron Le Matin	125mL	100% Full	Opened to test, sprayed once	$69	Designer
227	Caron	Pour un Homme de Caron Le Soir	125mL	100% Full	Opened to test, sprayed once	$69	Designer
228	Caron	Pour Un Homme Impact Parfum	75mL	97% Full	No Box	$175	Designer
229	Chanel	Allure Homme Sport - Aftershave Balm	100mL	99% Full	No Box	$65	Designer
230	Chanel	Allure Pour Femme EdT	100mL	100% Full	Tester; No Box	$65	Designer
231	Chanel	Bleu de Chanel - Aftershave Balm	100mL	99% Full	No Box, Minor Cosmetic Damage	$55	Designer
232	Chanel	Bleu de Chanel - Aftershave Lotion	100mL	99% Full	No Box, Minor Cosmetic Damage	$55	Designer
233	Chanel	Coco EdP	100mL	100% Full	Tester; No Box	$85	Designer
234	Chanel	Coco Mademoiselle - Moisturizing Body Lotion	200mL	99% Full	No Box	$55	Designer
235	Chanel	Coco Noir	100mL	100% Full	Tester; No Box	$100	Designer
236	Chanel	Cristalle Eau Vert EdT Concentree	100mL	100% Full	Tester; No Box	$135	Designer
237	Chanel	Cristalle EdP	50mL	95% Full	Tester; No Box	$135	Designer
238	Chanel	Gabrielle Essence	100mL	100% Full	Tester; No Box	$100	Designer
239	Chanel	No. 19	100mL	100% Full	Tester; No Box	$115	Designer
240	Chanel	No. 5 Eau Premiere	100mL	100% Full	Tester; No Box	$85	Designer
241	Chanel	No. 5 EdP	100mL	100% Full	Tester; No Box	$95	Designer
242	Chanel	Platinum Egoiste	75mL	99% Full	SPLASH, NOT SPRAY Older Formulation	$125	Designer
243	Christian Dior	Dior Homme Parfum	100mL	100% Full	Brand New, Sealed (Packaging may be slightly damaged)	$175	Designer
244	Christian Dior	J'adore in Joy EdT	100mL	100% Full	Tester with Cap, No Box	$60	Designer
245	Floris	Cefiro	100mL	100% Full	Tester with Cap, No Box	$59	Designer
246	Gucci	Gucci Guilty Absolute	90mL	100% Full	Tester; No Box	$70	Designer
247	Guerlain	Habit Rouge Parfum	100mL	100% Full	Brand New, Sealed	$130	Designer
248	Guerlain	L'Homme Ideal Parfum	100mL	100% Full	Brand New, Sealed	$130	Designer
249	Guerlain	L'instant de Guerlain Pour Homme EXTREME	10mL	100% Full	VINTAGE BLACK RIM - DECANT	$50	Designer
250	Guerlain	Vetiver Parfum	100mL	100% Full	Brand New, Sealed	$130	Designer
251	Hermes	Twilly	80mL	100% Full	Tester; No Box	$65	Designer
252	Jo Malone	Amber & Lavender	30mL	90% Full	No Box	$52	Designer
253	Jo Malone	English Oak & Redcurrant	30mL	80% Full	No Box	$49	Designer
254	Jo Malone	English Pear & Freesia	100mL	100% Full	Brand New with Gift Box and Gift Set (Body Wash, Body Lotion)	$180	Designer
255	Jo Malone	Rose & White Musk Absolu	100mL	100% Full	No Box	$180	Designer
256	Jo Malone	Scarlett Poppy Cologne Intense	100mL	100% Full	Tester; No Box	$130	Designer
257	Lalique	Ombre Noire	100mL	100% Full	Sealed	$100	Designer
258	Maison Martin Margiela	Replica - Jazz Club	100mL	100% Full	Tester (No Box)	$80	Designer
259	Thierry Mugler	A*MEN	100mL	99% Full	Rubber Flask; No Box	$75	Designer
260	Amouage	Cristal and Gold Ladies	50mL	95% Full	Vintage, Incredibly hard to find. Full presentation in nice condition	$399	Vintage
261	Cartier	Santos EdT	100mL	100% Full	Spray; Refill.	$299	Vintage
262	Chanel	Gardenia EdT	100mL	100% Full	Vintage; Sealed	$350	Vintage
263	Crabtree & Evelyn	Crabtree & Evelyn Extract of West Indian and Sicilian Limes	125mL	100% Full	Full presentation with Box	$209	Vintage
264	Dunhill	Cologne	125mL	99% Full	Vintage; Splash	$100	Vintage
265	Ermenegildo Zegna	Haitian Vetiver	125mL	99% Full	No Box	$300	Vintage
266	Escada	Pour Homme Aftershave	75mL	100% Full	BNIB Sealed	$165	Vintage
267	Escada	Pour Homme Aftershave	125mL	100% Full	BNIB Sealed	$240	Vintage
268	Floris	Special 127	100mL	98% Full	Vintage; Dark Blue Box., 2 Royal Warrants, Vintage Version	$70	Vintage
269	Fragonard	Zizanie	240mL	80% Full	Shaker bottle (Splash, not spray) no box. At least 80% Full.	$240	Vintage
270	Geo F Trumper	Ajaccio Violets	100mL	99% Full		$40	Vintage
271	Gucci	Envy Aftershave	50mL	100% Full	BNIB Sealed	$140	Vintage
272	Gucci	Envy Aftershave	100mL	100% Full	BNIB Sealed	$215	Vintage
273	Gucci	Rush for Men	50mL	100% Full	Full Presentation; These do not come fully filled	$190	Vintage
274	Gucci	Rush for Men Aftershave	100mL	100% Full	BNIB Sealed	$140	Vintage
275	Guerlain	Heritage EdT	200mL	100% Full	New; Vintage; Splash. 1991 Bottle.	$225	Vintage
276	Guerlain	Samrasa EdP	50mL	100% Full	No Box	$109	Vintage
277	Guerlain	Samsara EdT 1992-1993 Formulation	100mL	100% Full	Tester; No Cap; No Box	$109	Vintage
278	Jean Desprez	Bal a Versailles	9 Oz	70% Full	Vintage; Splash; No Box Open to offers on this enormous bottle.	$135	Vintage
279	Lacoste	Eau de Sport Vivifiante	100mL	99% Full	No Box	$110	Vintage
280	Lacoste	Land	100mL	99% Full		$130	Vintage
281	Nino Cerruti	Fair Play Pour Homme	100mL	99% Full	Full presentation with Box	$275	Vintage
282	Paco Rabanne	Eau de Metal	20mL	100% Full	Vintage; Mini	$15	Vintage
283	Revillon	Pour Homme Eau de Toilette Super Concentrate	60mL	99% Full	Atomizer	$190	Vintage
284	Revillon	Pour Homme Eau de Toilette Super Concentrate	90mL	99% Full	Atomizer	$290	Vintage​

Are you gearing up to take the CELPIP (Canadian English Language Proficiency Index Program) exam? As one of the premier language proficiency tests for Canadian immigration and citizenship, understanding its intricacies and preparing strategically can significantly enhance your chances of success. Here’s a comprehensive guide to help you ace the CELPIP exam on your first attempt.
What is CELPIP?
CELPIP is a computer-delivered English language proficiency test designed to assess functional language skills in real-life contexts, particularly relevant for those seeking to immigrate to Canada or obtain Canadian citizenship. The test evaluates four key language skills: Listening, Reading, Writing, and Speaking, with tasks tailored to everyday situations encountered in work, school, or social environments.
Tips to Ace the CELPIP Exam:
1. Familiarize Yourself with the Test Format: Take advantage of practice materials and sample tests provided by CELPIP to acquaint yourself with the test structure and question types. Understanding the format will help you navigate the exam confidently on test day.
2. Develop Strong Time Management Skills: Since CELPIP is a timed exam, efficient time management is crucial. Practice completing tasks within the allocated time limits during your preparation to build speed and accuracy.
3. Enhance Your Listening Skills: Focus on improving your listening comprehension by regularly listening to English podcasts, news broadcasts, and audio recordings. Pay attention to key details, main ideas, and nuances in spoken language.
4. Sharpen Your Reading Strategies: Practice skimming and scanning techniques to quickly extract information from written passages. Pay attention to keywords and context clues to aid comprehension and answer questions effectively.
5. Hone Your Writing and Speaking Abilities: Practice writing essays and delivering spoken responses under timed conditions. Work on organizing your ideas coherently and articulating them clearly. Seek feedback from tutors or peers to identify areas for improvement.
By following these expert tips and dedicating consistent effort to preparation, you can approach the CELPIP exam with confidence and increase your likelihood of achieving a successful outcome on your first attempt.
Join our vibrant community of language enthusiasts at GCILanguage and let's embark on a transformative CELPIP journey together.
If you have any further questions, you can reach us directly at [+1 604-755-4334](tel:+16047554334) in Surrey. We will be happy to assist you and answer any questions you may have.
To learn more about GCI Language Centre and its CELPIP preparation courses in Surrey, visit https://gcilanguage.com/ today.

The global brain implants market is expected to witness substantial growth, with a projected compound annual growth rate (CAGR) of 9%, reaching a valuation exceeding USD 4.5 billion in 2020. The escalating prevalence of conditions such as Alzheimer's disease and Parkinson's disease worldwide stands out as a primary driver propelling market expansion. Moreover, the growing awareness surrounding the benefits of brain implants is poised to further bolster market growth. Additionally, the introduction of advanced technologies by industry leaders such as Medtronic and Neurowave is anticipated to significantly contribute to market advancement throughout the forecast period.
To know more about this study, request a free sample report @ https://www.researchcorridor.com/request-sample/?id=2129
Market Trends:
Miniaturization and Wireless Technology: There's a growing trend towards miniaturization and the development of wireless brain implants, allowing for less invasive procedures and enhanced patient comfort. Wireless connectivity enables real-time data transmission and remote monitoring, facilitating more efficient diagnosis and treatment.
Advancements in Neurostimulation: Neurostimulation techniques, including deep brain stimulation (DBS), spinal cord stimulation (SCS), and vagus nerve stimulation (VNS), continue to evolve with improved electrode designs, programming algorithms, and targeting precision. These advancements enhance the efficacy and customization of neurostimulation therapies for various neurological disorders.
Closed-Loop Systems: Closed-loop or adaptive neurostimulation systems, which adjust stimulation parameters in response to neural activity, are gaining traction for their potential to optimize therapeutic outcomes while minimizing side effects. These systems offer personalized treatment approaches tailored to individual patient needs and disease progression.
Expanding Applications Beyond Movement Disorders: While historically used primarily for movement disorders such as Parkinson's disease and essential tremor, brain implants are increasingly being explored for a wider range of neurological and psychiatric conditions. These include epilepsy, depression, obsessive-compulsive disorder (OCD), chronic pain, and Alzheimer's disease, expanding the market's scope and potential.
Integration of Artificial Intelligence (AI) and Machine Learning: The integration of AI and machine learning algorithms into brain implants enables advanced data analysis, pattern recognition, and predictive modeling. AI-powered implants can adapt stimulation parameters in real-time based on patient-specific responses and evolving disease dynamics, optimizing treatment efficacy and patient outcomes.
Market Opportunities:
The brain implants market presents several opportunities for growth and innovation. With advancements in technology and expanding clinical indications, there is a significant opportunity to address unmet medical needs and improve patient outcomes across a wide range of neurological and psychiatric conditions. Opportunities exist for the development of next-generation brain implants with enhanced functionality, miniaturization, and wireless connectivity, enabling less invasive procedures and improved patient comfort. Moreover, the integration of artificial intelligence and machine learning algorithms presents opportunities to personalize treatment approaches and optimize therapeutic outcomes based on individual patient responses. Additionally, the expanding applications of brain implants beyond movement disorders, including epilepsy, depression, chronic pain, and Alzheimer's disease, offer avenues for market expansion and diversification.
According to the recent report published by RC Market Analytics, the Global Brain Implants Market is expected to provide sustainable growth opportunities during the forecast period from 2024 to 2030. This latest industry research study analyzes the brain implants market by various product segments, applications, regions and countries while assessing regional performances of numerous leading market participants. The report offers a holistic view of the brain implants industry encompassing numerous stakeholders including raw material suppliers, providers, distributors, consumers and government agencies, among others. Furthermore, the report includes detailed quantitative and qualitative analysis of the global market considering market history, product development, regional dynamics, competitive landscape, and key success factors (KSFs) in the industry.
Browse the Full Report Discretion @ https://www.researchcorridor.com/brain-implants-market/
Geographically, the brain implants market report comprises dedicated sections centering on the regional market revenue and trends. The brain implants market has been segmented on the basis of geographic regions into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Brain implants market estimates have also been provided for the historical years 2020 to 2023 along with forecast for the period from 2024 - 2030.The report includes a deep-dive analysis of key countries including the U.S., Canada, the U.K., Germany, France, Italy, China, Japan, India, Australia, Mexico, Brazil and South Africa, among others. Thereby, the report identifies unique growth opportunities across the world based on trends occurring in various developed and developing economies.
The Brain Implants Market Segmentation:
By Type:

• Deep Brain Stimulator
• Spinal Cord Stimulator
• Vagus Nerve Stimulator

By Application:

• Chronic Pain
• Epilepsy
• Parkinson’s Disease
• Depression
• Essential Tremor
• Alzheimer’s Disease

By End-User:

• Hospitals
• Clinical Trials Centers
• Others

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key players in the global brain implants market include Medtronic, Boston Scientific Corporation, Nuvectra Corporation, St. Jude Medical (Abbott), NeuroPace, Inc., and Nevro Corporation. These companies are actively pursuing market opportunities through various strategies such as expansion initiatives, new investments, service innovations, and collaborative ventures. Furthermore, players are seeking to strengthen their market position through geographical expansion and strategic acquisitions, aiming to leverage combined synergies for a competitive edge.
To know more about this study, request a free sample report @ https://www.researchcorridor.com/request-sample/?id=2129
Key Questions Answered by Brain Implants Market Report:

• Product popularity and adoption based on various country-level dynamics
• Regional presence and product development for leading market participants
• Market forecasts and trend analysis based on ongoing investments and economic growth in key countries
• Competitive landscape based on revenue, product offerings, years of presence, number of employees and market concentration, among others
• Various industry models such as SWOT analysis, Pestle Analysis, Porter’s Five Force model, Value Chain Analysis pertaining to Brain Implants market
• Analysis of the key factors driving and restraining the growth of the global, regional and country-level markets from 2020-2030

About Us:RC Market Analytics is a global market research firm. Our insightful analysis is focused on developed and emerging markets. We identify trends and forecast markets with a view to aid businesses identify market opportunities to optimize strategies. Our expert’s team of analysts’ provides enterprises with strategic insights. RC Market Analytics works to help enterprises grow through strategic insights and actionable solutions. Feel free to contact us for any report customization at sales@researchcorridor.com.
Media Contact:
Company Name: RC Market Analytics Pvt. Ltd. Contact Person: Vijendra Singh Email: sales@researchcorridor.com Visit us: https://www.researchcorridor.com/

I spoke with our geneticist already but wanted to hear if anyone has gone through something similar before or if any genetic specialists can help me interpret the situation.
Our microarray results came back normal HOWEVER the geneticist called us to explain that :

• when they initially ran the test with the direct cells taken from the amnio, "There was a 400kb deletion of a clinically significant gene (NBEA), but the log ratio is not as deep as we would typically expect." < in other words, not a clear deletion but system did flag it
  
• they cultured the cells and ran the array test again as well as a FISH on that specific region and both tests were normal. Notes say: "We do see a region of absence of heterozygosity at this locus in both the fetus and mother, which we think may have triggered the software to overcall it as a deletion"
  
• based on this, they reported back a "Normal" result but wanted to let us know of the earlier finding because it's a genetically significant finding associated with a rare but severe neurological condition. Also, technically there could be a difference between the cells in the direct sample vs the cultured one.
  

The only option they gave us to get more assurance on this is to do another amnio so they can run a FISH on that specific area.
My thinking/questions: - it sounds like the genetics team has already done a lot of due diligence to confidently say its a false positive, so the chance this is a true positive is very low (probably lower than risk of another amnio?) - on the chance of direct cells giving a different result than the cultured cells, don't a lot of microarrays get done based on cultured cells anyway? - should we even be worrying about this based on everything we know already? For context - 4.6mm NT, normal expanded NIPT, normal 16 and 20wk anatomy scans and fetal echos, normal FISH results on the 3 trisomys and sex chromosome
Any thoughts/opinions would be appreciated!

Hi all,
Appreciate past feedback from you guys!
After a failed walk forward test I turned my algo off and re-assessed - I know the foundation of my strategy is sound but it was too heavily reliant on various parameters that I seemingly overfit.
Iv stripped this back to basics, core strategy only and currently have this on forward testing on a demo environment as, although my live forward testing failed I did gather all the data I needed on slippage and excitation.
Here is my back test results for my system, I would really appreciate any feedback in regards to the assets traded, although I can "optimise" it to work on a larger variety if securities, it works out of the box with very minimal parameters (just stop loss adjustments) - I have accounted for spreads (averaged) but not interest or holding fees (minimal)
My concerns are:
1: Correlation
2: The shape of the curve picks up in 2018 but really seems to take off
3: Lack of data on some assets that done extend to the start of testing
4: The poor performance from 2012 to 2018 on most securities.
https://preview.redd.it/6ueqehnv5f0d1.png?width=1201&format=png&auto=webp&s=fa22fa8697fde9cf881b8a729cea6e5e2d5f414a

About two months ago I (34F) started having stomach aches/cramping, changes in bowel habits and a feeling like something was stuck or like I wasn’t done even if I’d just gone to the bathroom or knew I didn’t need to go. I went to a GI about two weeks later and she said it could be colitis or IBS, she called for a FIT test and blood work (both came back normal) and a six week diet (two weeks gluten free, two lactose free and two fodmap). While the stomach pains went away, the changes in bowel and the feeling of something stuck or incomplete did not go away. I had a follow up yesterday and now she has ordered a colonoscopy for a month from now. She mentioned it could be internal hemorrhoids or colitis and also said she’s not worried but still wants to go in and look. Even though she seems unconcerned I am terrified. My worst fear is that it could be something much more serious and that diagnosis is taking too long. My question is do those of you who have experienced similar symptoms agree with her assessment or could my fears be valid and I should do more to get answers sooner? All thoughts welcome, thank you in advance.

Anyone else waiting? How long did it take for those who sent embryos for testing recently. I am so stressed sitting by my phone just waiting for the call. Samples were overnighted on 5/3.

About two months ago I (34F) started having stomach aches/cramping, changes in bowel habits and a feeling like something was stuck or like I wasn’t done even if I’d just gone to the bathroom or knew I didn’t need to go. I went to a GI about two weeks later and she said it could be colitis or IBS, she called for a FIT test and blood work (both came back normal) and a six week diet (two weeks gluten free, two lactose free and two fodmap). While the stomach pains went away, the changes in bowel and the feeling of something stuck or incomplete did not go away. I had a follow up yesterday and now she has ordered a colonoscopy for a month from now. She mentioned it could be internal hemorrhoids or colitis and also said she’s not worried but still wants to go in and look. Even though she seems unconcerned I am terrified. My worst fear is that it could be something much more serious and that diagnosis is taking too long. My question is do those of you who have experienced similar symptoms agree with her assessment or could my fears be valid and I should do more to get answers sooner? All thoughts welcome, thank you in advance.

My details:
35M, 5’11, 280lbs, Caucasian, confirmed diagnosis of hypertrophic cardiomyopathy (apical variety) and essential hypertension (controlled), currently taking 2.5mg bisoprolol and 7.5mg ramipril, I do not nor have ever smoked, I do not drink alcohol, I do not nor have ever used recreational or performance enhancing drugs, UK.
Context:
I was diagnosed with apical HCM after several heart tests. My ECG is here if it helps. To manage my hypertension and HCM symptoms, I’m on bisoprolol (2.5mg) and ramipril (7.5mg).
I don’t have syncope. I do not suffer from breathlessness during regular activities (but obviously get out of breath if I'm exercising). I sometimes experience chest tightness (not pain) while exercising, however this does not occur if I train in a fasted state (which I find odd). I occasionally get palpitations but no other known heart rhythm issues.
My cardiologist’s care is slow-moving, and I don't have direct access for queries. I need advice on safe exercise with HCM. Post-diagnosis, the cardiologist advised ‘light to moderate’ exercise, but I’m unclear on specifics.
Although overweight, I was previously very active. I did hiking, sprinting, e-biking, and powerlifting. However, since my diagnosis, I've been seriously put off exercise given the risk of SCD with HCM. It is my understanding that walking, hiking, and biking are fine if I keep an eye on my heart rate (target under 140 BPM). I also understand powerlifting and sprinting is out as these are high intensity. However, I’m unsure about resistance training more broadly and would love some advice.
Questions:

1. Is it advisable for me to perform any form of resistance training, considering my age (35) and desire to maintain strength and mobility into older age? While I understand that powerlifting (high weight, low rep, with Valsalva manoeuvre) is off-limits, could I participate in high repetition, lower weight resistance exercises without Valsalva manoeuvre?
2. I’m puzzled about why maintaining an average heart rate of 130bpm during a 30-minute bike ride or walk is deemed safer than a light whole-body weightlifting session that also keeps my heart rate at 130bpm. Am I overlooking a factor other than heart rate that makes certain exercises riskier for someone with HCM? If so, what is it?
3. I appreciate this forum may not be able to provide me an answer at all. However, if you cannot provide an answer to the above two questions, would you be able to tell me if there specific tests or tools that could clarify whether I can safely continue weightlifting with HCM? I’ve heard of athletes with HCM who still compete, suggesting there are methods to assess this. Knowing about these could facilitate a productive discussion with my cardiologist and allow me to request a referral.

I would be grateful for any help you can offer. Thank you.

Mast cell activation syndrome (MCAS) is the subject of heated debate. How are mast cell activation syndromes defined? Which diseases are included? What is the diagnosis and treatment of mast cell activation syndrome? Prof. Dr. Knut Brockow, Clinic and Polyclinic for Dermatology and Allergology at the Biederstein, Technical University of Munich answers these questions in an interview with MeinAllergiePortal.
Mast cell activation syndrome: The most important facts!
-The prototype of mast cell activation syndrome is recurrent anaphylaxis
-Other forms of idiopathic mast cell activation syndrome are being sought; however, there are mainly symptom descriptions where the diagnosis cannot be made
-Clinical suspicion of MCAS is based on recurring allergy-like symptoms on the skin, nose, respiratory tract, gastrointestinal tract and circulation
-The diagnosis of MCAS is made according to recognized international criteria based on three criteria
-MCAS is often suspected even when symptoms are inappropriate and the diagnosis is unclear; the suspicion is then not helpful for patients
-The same medications are used to treat MCAS as are used to treat allergies, in particular antihistamines and cromoglicic acid
Prof. Brockow, what kind of disease is MCAS?
Mast cell activation syndrome is not an established diagnosis, but rather a concept. Historically, this concept arose because an increasing number of patients came to the doctor's office with complaints that gave the impression of having been triggered by mast cells. These patients sometimes showed symptoms similar to those of allergic reactions, anaphylaxis or mastocytosis, but a clear diagnosis for these diseases could not be made. Nevertheless, it was suspected that there could at least be a connection with mast cell diseases. Unfortunately, the term MCAS created more uncertainty than understanding. This is because MCAS is now thrown around as a diagnosis for many patients with many symptoms and an unclear diagnosis. This is not helpful for patients and fuels short-term hope of diagnosis and cure, which cannot be fulfilled later.
Is MCAS an autoimmune disease?
No, in autoimmune diseases mast cells are not primarily involved and not as lead cells, but lymphocytes that attack the body's own structures, in some cases by forming antibodies.
Is there a connection between mast cell activation syndrome and autoimmune diseases?
No, there is no known connection between MCAS and autoimmune diseases. It has also been claimed by specific authors that other diseases, such as Ehlers-Danlos syndrome, postural orthostatic tachycardia syndrome (POTS) and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) are related to mast cell activation syndrome. However, there are no good arguments for this. Unfortunately, such claims are easy to make and difficult to refute.
What is the cause of mast cell activation syndrome?
Mast cell activation syndrome is actually more of a symptom description than a diagnosis in its own right. Mast cell activation syndrome is fully applicable to recurrent anaphylaxis (severe allergic reactions in several organ systems such as the skin, respiratory tract, digestive tract and circulatory system), for example due to insect bites. All the criteria for mast cell activation syndrome are met here. Severe allergic reactions are the most common cause of MCAS. However, although the term MCAS is correct in this context, it does not provide any additional information, as patients with such events are better described as patients with a diagnosis of anaphylaxis or allergy, and the term MCAS is somewhat confusing.
Is mast cell activation syndrome genetic?
MCAS itself is not genetic, but patients with the genetic disease mastocytosis often suffer from anaphylaxis, particularly to insect venom, and therefore MCAS. In addition, it is currently being investigated whether people with genetically determined hereditary alpha-tryptasemia suffer more frequently from MCAS.
How did the term mast cell activation syndrome come about?
There were many patients without a clear diagnosis, some of whom predominantly showed the symptoms typical of mast cell diseases. Accordingly, the experts dealing with mast cell diseases saw the need to develop a concept that took into account the “undiagnosable” symptoms of the patients. In the course of this, the terms “mast cell activation” and “mast cell activation syndrome” were defined. In addition, an attempt was made to sort all mast cell diseases into a classification with regard to mast cell activation. However, the difficulty in classifying these complaints is that many of the complaints described by patients are subjective, relatively non-specific and can be both organic and psychosomatic.
How have you defined mast cell diseases and which diseases do they include?
Mast cell diseases are defined as recurring chronic symptoms that are compatible with mast cell activation.
Mast cell activation is classified on the basis of three criteria:
Recurrent typical clinical symptoms in at least two organ systems
An increase in mast cell mediators can be detected in the blood, most frequently by determining the serum tryptase level during an acute attack
Good response of symptoms to anti-mast cell mediator-directed therapy, especially H1 antihistamines
What types of mast cell disease are there?
The classification of mast cell diseases associated with mast cell activation syndromes defines three groups:
1. primary mast cell activation syndrome
Primary mast cell activation syndrome is explained by a clonal expansion of mutated overactive mast cells. It manifests as systemic or cutaneous mastocytosis. If these criteria are not completely fulfilled, but clonal mast cells have been detected, it is referred to as monoclonal mast cell activation syndrome.
2 Secondary mast cell activation syndrome
Secondary mast cell activation syndrome is present when clear triggers of mast cell activation are known. There are established terms for secondary mast cell activation syndrome that we are more familiar with, such as “anaphylaxis” to a known trigger. The classification in the second group of mast cell diseases is therefore merely a reclassification. Examples of mast cell activation are physical urticaria or cold urticaria. Allergies such as pollen allergies are also secondary mast cell activations, as hay fever also causes symptoms typical of mast cell diseases. In pollen allergies, mast cell mediators are found in the blood serum and drugs directed against mast cells have a good effect. If the symptoms recur in several organ systems, this is referred to as mast cell activation syndrome.
3. tertiary or idiopathic mast cell activation syndrome
Tertiary or idiopathic mast cell activation syndrome refers to mast cell diseases whose triggers are unknown. This group would include, for example, chronic spontaneous urticaria, which has additional symptoms in other organs. Here we know that mast cells are activated, but not by what. This group of idiopathic mast cell activation syndromes would also include patients with as yet undescribed clinical pictures who do not fulfill the diagnostic criteria of known mast cell diseases, e.g. allergy, anaphylaxis, but in whom the disease is triggered by mast cells. In these patients, however, the connection between the symptoms and the activities of the mast cells must be proven.
Does this mean that tertiary or idiopathic mast cell activation syndrome is a diagnosis of exclusion?
Idiopathic mast cell activation syndrome can be described as a diagnosis of exclusion insofar as the prerequisite for the diagnosis is that there is no other disease causing the symptoms. However, the symptoms described are often very, very unspecific and could also be caused by a variety of other diseases. However, there are the three criteria for mast cell activation syndrome already mentioned. If these are not all fulfilled, this diagnosis cannot be made.
How common is mast cell activation syndrome?
Anaphylaxis and severe recurrent allergies are not uncommon and represent the vast majority of appropriate cases for MCAS. In addition, mastocytosis patients often have multiple anaphylaxis and therefore also MCAS. However, our initial idea of finding a new disease, idiopathic mast cell activation syndrome, has not yet been confirmed. There are many patients with many symptoms for whom a clear organic diagnosis cannot yet be made. However, it is almost never possible to prove that a defect in the mast cells is primarily responsible for the symptoms. Many of these patients describe symptoms that could fit, and in some patients anti-allergic drugs also have a positive effect. But in only very few patients can an increase in mast cell mediators be detected during an acute attack. I now believe that somatic stress disorders could play a significant role in many of the patients examined.
Histamine intolerance is also a diagnosis of exclusion, is there a connection with mast cell activation syndrome?
Histamine intolerance can cause similar symptoms, but is not a mast cell disorder and has nothing to do with MCAS. When mast cells are activated, the messenger substance histamine is released, which in turn can cause symptoms. In histamine intolerance, the mast cell is not activated - it is not involved in any way. Rather, histamine intolerance describes patients with an increased sensitivity to histamine, which is supplied, for example, via the diet. This can lead to similar symptoms, but in contrast to mast cell activation syndrome, histamine intolerance has a clear trigger, histamine. As a result, the symptoms occur after eating histamine-rich foods, but disappear again if the patient follows a low-histamine diet. A test is also available to diagnose histamine intolerance.
So there are also patients with suspected mast cell activation syndrome who cannot be assigned to a classification group, even though they have corresponding symptoms?
There are many patients in whom no mast cell activation syndrome can be detected despite suspicion. They do not fit into one of the three groups. However, this also used to include monoclonal mast cell activation syndrome. These patients showed anaphylaxis and a KIT mutation, but not the full criteria for mastocytosis. In the meantime, a separate disease diagnosis has been created for these patients. The independent accepted disease of these patients therefore lies between mastocytosis and normal findings.
We thought that there might be other forms of idiopathic MCAS with clinical pictures that have not yet been described. However, this is not supported by the findings to date. There are patients who show symptoms but do not meet the necessary criteria for idiopathic mast cell activation syndrome. In these patients, the diagnosis remains unclear. In how many of these patients functional physical complaints play a role still needs to be investigated.
Are there risk factors that favor mast cell activation syndrome?
There are hardly any recognized studies on this. In a study conducted by Cem Akin in the USA, patients were examined who met the three criteria for idiopathic mast cell activation syndrome. They had the right symptoms, there was an increase in mediators and their symptoms improved with treatment. It was shown that many of these patients suffered from urticaria factitia, a scratch-induced urticaria, abdominal pain and flushing.
Recently, a genetic trait was discovered, hereditary alpha-tryptasemia with elevated basal serum tryptase levels. In patients with this trait and insect venom allergy, the severity of the allergic reaction appears to be increased. It is also discussed that the frequency of mast cell activation syndrome is increased in patients with this genetic trait. However, the published studies are not yet unanimous in this respect.
What symptoms can occur with MCAS?
The following symptoms could be signs of mast cell activation syndrome:
MCAS symptoms on the skin:
Appearance of sudden intense redness (flushing)
itching
wheal formation
Deep wheal formation (angioedema or Quincke's edema)
MCAS symptoms on the nose:
Nasal congestion
Nasal itching
MCAS symptoms in the airways:
Swelling of the upper airways
Wheezing
Shortness of breath
MCAS symptoms of the digestive tract:
Vomiting
abdominal pain
diarrhea
Systemic MCAS symptoms:
Syncope - where you suddenly lose consciousness, but only for a short time
Sudden drop in blood pressure
Allergic shock
These symptoms can occur together or individually. In principle, symptoms must occur in two or more organ systems for MCAS. These symptoms, together with the typical skin changes and anaphylaxis, are also typical of mastocytosis.
Are muscle pain and hair loss also symptoms of MCAS?
No, why would anyone think that these symptoms are primarily caused by a malfunction of mast cells? Mast cells are not important cells for muscle pain and hair loss.
How is MCAS diagnosed?
MCAS is a diagnosis of exclusion, i.e. there is no mast cell activation syndrome test. However, this does not mean that all other diseases must be ruled out before a diagnosis of MCAS can be made.
When testing directly for mast cell activation syndrome, three criteria would be examined, all of which must be met, not just two:
First, there must be a matching of symptoms to see if the above symptoms are leading, recurrent and occur in at least two organ systems.
Is there a substantial or complete improvement in the clinical symptoms when taking anti-allergic medication, antihistamines or cromoglicic acid? Then this criterion would apply.
The blood levels of tryptase in the serum can now be examined at two different points in time. This would check whether there is an increase in mast cell mediators or tryptase in the blood serum in a highly symptomatic phase or during a seizure compared to a time when there are no symptoms.
What does the tryptase level in the blood mean in the diagnosis of mast cell activation syndrome?
If the mast cell mediator tryptase rises by 20 percent of the basal value, i.e. the initial value, + 2 ng/ml during such an episode, the diagnosis of mast cell activation syndrome has been made without the need to rule out other diseases beforehand. However, taking blood samples to determine the tryptase levels is very time-consuming, because a blood sample should be taken in the normal state and then another blood sample should be taken during a seizure or a highly symptomatic episode. This means that the patient must see a doctor in good time for a blood test during the acute phase. If these tests are negative, mast cell activation syndrome cannot be confirmed.
Elevated tryptase levels also play a role in anaphylaxis, is there a connection with mast cell activation syndrome?
Anaphylaxis is an extremely strong mast cell activation, the “prototype” of mast cell activation, so to speak. The tryptase level rises, so that it is considered an indicator of anaphylaxis. Here too, the basal value is measured and compared with the value during an episode. The relevant factor is the resulting increase in the tryptase value. The therapy against mast cells is effective in this case. In this respect, anaphylaxis is the classic form of mast cell activation syndrome.
The tryptase value also plays a role in the diagnosis of mastocytosis, what are the correlations here?
Mastocytosis patients also have an elevated baseline tryptase level. This is therefore an indication of mastocytosis and an indication for a final diagnosis by means of a bone marrow biopsy. However, there is also a mastocytosis-independent correlation between tryptase and anaphylaxis. People who have a higher number of mast cells often develop more severe anaphylaxis than people with fewer mast cells. The tryptase basal value is therefore considered a kind of indicator for the total mast cells in the body. For example, insect venom anaphylactic patients with elevated basal mast cell tryptase levels in the blood are at increased risk of severe anaphylaxis.
What can be done against MCAS and which medications help?
The aim of treatment for mast cell activation syndrome is to slow down the effect of the overactivated mast cells and to calm the mast cells. In particular, the avoidance of allergic triggers is available for this purpose.
Histamine receptor blockers are tried as medication to block the effects of mast cell activation by histamine. Mast cell stabilizers or blockers of mast cell release, cromoglicic acid, can also calm the mast cells. Cromoglicic acid is also used in mastocytosis patients. It is important to know that the use of cromoglicic acid is not advisable if the attack has already run its course. On the other hand, many patients achieve a significant improvement in symptoms if cromoglicic acid is taken continuously as a preventive measure and in a sufficiently high dose. This has also been shown to be the case with antihistamines.
Another option would be leukotriene receptor antagonists and corticosteroids in the short term, but never over a longer period of time.
Unfortunately, many patients with previously unexplained complaints are given a suspected diagnosis of MCAS in the hope that this knowledge will lead to better treatment or perhaps a cure. However, apart from the drugs mentioned, which can also be used on a trial basis in cases of suspected MCAS, there are no other useful drugs available. In this respect, the suspicion of MCAS unfortunately does not offer patients any additional treatment options.
Are there foods that activate or deactivate mast cells?
No such foods are known in humans. Of course, it is possible to bombard mast cells in a test tube with high concentrations of food and measure whether the natural activation of mast cells is increased or reduced. However, such tests are generally not meaningful for humans when consumed.
Can naturopathy help with mast cell activation syndrome?
I don't know how it could help. Naturopathy is the attempt to achieve a positive effect through naturally occurring active substances. Is the avoidance of allergens in our natural environment already naturopathy?
Could certain vitamins, for example vitamin C, be beneficial for MCAS?
This is claimed by a few doctors without any convincing results. Vitamin C is also said to help against seasickness. After all, vitamin C, taken in normal amounts, is not harmful and is beneficial. Sometimes the conviction that a substance is good for you also helps. That's why the experiment doesn't bother me.
Is it possible to prevent mast cell activation syndrome?
Yes, by avoiding MCAS with a known trigger. This is the case with allergies. In the case of allergies and recurrent anaphylaxis as a form of MCAS, omalizumab, an antibody against immunoglobulin E, can also be used in individual patients.
Prof. Brockow, thank you very much for this interview!
https://www.mein-allergie-portal.com/mastozytose-mastzellaktivierungssyndrom-mcas/925-idiopathisches-mastzellenaktivierungssyndrom-ein-neues-krankheitsbild.html

The global warfarin market is projected to experience substantial growth, with a notable compound annual growth rate (CAGR) of 2.4%, potentially reaching USD 2,732 million by 2027. This growth is primarily attributed to the rising prevalence of atrial fibrillation worldwide, contributing to an increased demand for warfarin. Additionally, the effective implementation of treatment guidelines related to the management of deep vein thrombosis/pulmonary embolism (DVT/PE) further amplifies the market's growth trajectory.
To know more about this study, request a free sample report @ https://www.researchcorridor.com/request-sample/?id=21770
Market Trends:
Shift Towards Novel Oral Anticoagulants (NOACs): There is a noticeable trend towards the adoption of Novel Oral Anticoagulants (NOACs) as alternatives to traditional warfarin therapy. NOACs offer advantages such as rapid onset of action, predictable pharmacokinetics, and fewer dietary and drug interactions compared to warfarin, driving a gradual shift in treatment preferences.
Personalized Medicine Approaches: With advancements in pharmacogenomics, there is growing interest in personalized medicine approaches for anticoagulant therapy, including warfarin dosing. Genetic testing for variants in genes such as CYP2C9 and VKORC1 enables healthcare providers to tailor warfarin dosages more precisely, minimizing the risk of adverse events and improving treatment outcomes.
Increasing Focus on Patient Monitoring and Management: There's a heightened emphasis on patient monitoring and management to optimize the efficacy and safety of warfarin therapy. Innovations in point-of-care testing devices, remote monitoring solutions, and patient education programs empower patients and healthcare providers to manage anticoagulation therapy more effectively, reducing the risk of complications such as bleeding and thrombosis.
Integration of Digital Health Technologies: Digital health technologies, including mobile applications, wearables, and telemedicine platforms, are being integrated into anticoagulation management workflows to enhance patient engagement, adherence, and clinical outcomes. These technologies enable real-time communication between patients and healthcare providers, facilitating remote monitoring, medication adherence tracking, and timely intervention when needed.
Focus on Safety and Bleeding Risk Mitigation: Efforts to minimize the risk of bleeding complications associated with warfarin therapy remain a key focus area in anticoagulation management. Strategies such as dose optimization, regular monitoring of International Normalized Ratio (INR) levels, and patient education on bleeding risk factors and precautions are essential for ensuring the safe and effective use of warfarin.
Market Opportunities:
The Warfarin market presents several opportunities for growth and innovation. With the increasing prevalence of cardiovascular diseases, including atrial fibrillation and venous thromboembolism, there is a growing demand for anticoagulant therapies such as Warfarin. Opportunities exist for pharmaceutical companies to develop and commercialize novel formulations, combination therapies, and dosage forms to address unmet medical needs and improve patient outcomes. Additionally, advancements in pharmacogenomics offer opportunities for personalized medicine approaches, including genetic testing to optimize Warfarin dosing and minimize the risk of adverse events. Integration of digital health technologies such as mobile applications, wearables, and telemedicine platforms presents opportunities to enhance patient engagement, medication adherence, and remote monitoring of anticoagulation therapy.
According to the recent report published by RC Market Analytics, the Global Warfarin Market is expected to provide sustainable growth opportunities during the forecast period from 2024 to 2030. This latest industry research study analyzes the warfarin market by various product segments, applications, regions and countries while assessing regional performances of numerous leading market participants. The report offers a holistic view of the warfarin industry encompassing numerous stakeholders including raw material suppliers, providers, distributors, consumers and government agencies, among others. Furthermore, the report includes detailed quantitative and qualitative analysis of the global market considering market history, product development, regional dynamics, competitive landscape, and key success factors (KSFs) in the industry.
Browse the Full Report Discretion @ https://www.researchcorridor.com/warfarin-market/
Geographically, the warfarin market report comprises dedicated sections centering on the regional market revenue and trends. The warfarin market has been segmented on the basis of geographic regions into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Warfarin market estimates have also been provided for the historical years 2020 to 2023 along with forecast for the period from 2024 - 2030.The report includes a deep-dive analysis of key countries including the U.S., Canada, the U.K., Germany, France, Italy, China, Japan, India, Australia, Mexico, Brazil and South Africa, among others. Thereby, the report identifies unique growth opportunities across the world based on trends occurring in various developed and developing economies.
The Warfarin Market Segmentation:
By Clinical Application:

• Atrial Fibrillation
• DVT/PE
• Others

By Distribution Channel:

• Hospital Pharmacy
• Retail Pharmacy
• Others

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Prominent companies in the global Warfarin market include Bristol-Myers Squibb Company, Apotex Corporation, Zydus Healthcare, Cipla Limited, and Teva Pharmaceutical Industries Limited. These firms are actively navigating market landscapes through various strategies such as expansion initiatives, fresh investments, service innovations, and collaborative ventures. Additionally, players are venturing into new geographical territories through expansion and acquisition endeavors, aiming to harness joint synergies for a competitive edge.
To know more about this study, request a free sample report @ https://www.researchcorridor.com/request-sample/?id=21770
Key Questions Answered by Warfarin Market Report:

• Product popularity and adoption based on various country-level dynamics
• Regional presence and product development for leading market participants
• Market forecasts and trend analysis based on ongoing investments and economic growth in key countries
• Competitive landscape based on revenue, product offerings, years of presence, number of employees and market concentration, among others
• Various industry models such as SWOT analysis, Pestle Analysis, Porter’s Five Force model, Value Chain Analysis pertaining to Warfarin market
• Analysis of the key factors driving and restraining the growth of the global, regional and country-level markets from 2020-2030

About Us:RC Market Analytics is a global market research firm. Our insightful analysis is focused on developed and emerging markets. We identify trends and forecast markets with a view to aid businesses identify market opportunities to optimize strategies. Our expert’s team of analysts’ provides enterprises with strategic insights. RC Market Analytics works to help enterprises grow through strategic insights and actionable solutions. Feel free to contact us for any report customization at sales@researchcorridor.com.
Media Contact:
Company Name: RC Market Analytics Pvt. Ltd. Contact Person: Vijendra Singh Email: sales@researchcorridor.com Visit us: https://www.researchcorridor.com/

I am in Puerto Vallarta, Mexico and will be going for four different stem cell treatments today with DBC.
I will be doing 300 million IV, 50 million intrathecal IV (injected in the spinal cord) 25 million nebulized treatment (breathed in via nebulizer) and finally will get 50 million stem cells + PRP injected directly into my penis.
I am a 27 year old male, physically fit, but have a host of different health problems that I think stem cells may help (sorted from most important to least important):

1. IBS, loose stools, food intolerances
2. Poor sleep/rest
3. Fatigue
4. Brainfog, problems with focus and working memory
5. Some arthritis and also proneness to tendonitis
6. Urinary incontinence
7. Inflamed skin, acne
8. Scar tissue in nostrils, damaged mucus membranes, excess mucus in throat
9. Bronchitis

After returning from Mexico I will also start using BPC-157 (peptide), growth hormone and a full body high intensity PEMF device (pulsed electromagnetic field therapy) daily.
In addition to this I have planned to do testing for food intolerances (I do know somewhat what I handle and not already) and be more strict with elimination and also a CSAPx2 stool sample/gut microbiome analysis and implement steps based on the results.
Now it might be hard to say what potential progress or improvement can be accredited to the MSCs and what will be accredited to the different modalities I will be using, but if it's of any interest to the community I can update you on the potential changes I experience.
I do suspect the stem cells will have the largest impact.
Let me know if this is of any interest.
Much love.

First of all, thank you so much for this community and the people who have responded to my questions and provided helpful tips and tricks - I could not have passed without y'all's guidance. I do not have formal project management experience, I have a PhD in Social Sciences so I had experience managing research projects and am currently working in government, so I manage small and medium size projects. Here is my experience and some tips that may help you as you are preparing for the exam:
[These are all my personal experiences]

1. General: This is not an easy exam: Please study all the processes, abbreviations, specific contents within subtopics (such as what are the 5 ways to deal with negative risks, etc). Although everyone says you don't need to memorize, there are some things that memorizing will help you out a lot in addition to understanding.
2. Study Materials: Primarily used AR's Udemy course for preparation - he was my best friend for 3 months. I watched that course twice in 1.75 speed, and took detailed notes on processes. Got 75% on his mock exam. I bought study hall and I used it for the mock exams and practice questions. I scored 63% on the first mock and 67% on the second [with expert questions]. On the mini sections, I would score 65-70 with expert questions and 83-85 without expert. I realized that the expert questions just confused me, so I started ignoring them closer to the exam date. I have a long commute to work, so I also listened to Scott Payne's PMP prep book on Audible. This guy is so fun and incredible, and uses very engaging case studies to help you learn. If you're like me and are able to focus on audiobooks, I strongly recommend him. I only discovered David Maclachlan a week-ish before the exam date, so I would just look at his YouTube videos for 30 mins - 1 hour before going to bed.
3. Mindset: Nail this down. Even when questions seemed confusing, AR's mindset came to my rescue because I was at least able to eliminate choices that deal with escalating things to the management. Along with his mindset, here are some things that I learned by doing the questions again and again:

• Whenever there is a conflict, speak to BOTH parties, not just one.
• The answer almost always starts with “review,” “plan,” “assess,” “sit down with,” “evaluate” AS OPPOSED to with “perform,” “change,” conduct,” because you always want to evaluate the situation before jumping to action
• Removing team member should be the last resort UNLESS they do something unethical
• I know AR keeps saying that co location is the best option - IT IS NOT WHEN THERE ARE GEOGRAPHICAL AND BUDGET LIMITATIONS (This may be too obvious for most people but wasn't for me, LOL)

4. Exam day prep: EAT and hydrate please. I was so nervous, so I thought I wasn't hungry, but I downed a whole sandwich before the test (It was at 2 PM, I am not a morning person), and that helped me sustain my pace throughout the exam. I used the two breaks and drank water and did some stretches. I asked the test center people for a calculator and they gave it to me, although there was no question that required any calculation.

• Even if the section is on the easier side, DO NOT RELAX too much. I finished with 6 minutes to spare and was rushing towards the end.
• DO NOT LOSE HOPE if some questions are hard on a row. Keep going, keep flagging, keep using mindset. KEEP GOING.
• I suggest to not take any mock exam on the day of or even a day before the exam. These tests are so draining, so relax, do something fun, eat good, and give it your all at the exam.

1. Other: I blocked at least 2 hours per weekday for 3 months to study

I hope this note helps you as you are preparing for your certification, I am rooting for you!

18 super samples an hour.
I’m sure something similar is posted elsewhere but none of the other guides have worked for me. I can’t consistently find the rock on the map and usually spend too much time looking and get whacked by a patrol and can’t recover.
What has worked for me is this and it works on suicide missions and above, solo or with a team of friends on the same page.

1. Select a blitz mission, bots or bugs, doesn’t matter but I’ve found bots are easier to outrun if you get caught and bug breaches on helldive are just crazy.
   
2. Wear scout armor that decreases your detectable range.
   
3. Drop in a clear area near extraction to get set up.
   
4. You can pretty easily avoid most enemies.
   
5. Make your way around the map until you find the radar tower (so far there has always been one on blitz) or you find the thumb rock. You can easily avoid the main and sub objectives as well.
   
6. ALL super samples in a blitz mission spawn together so 6 on Helldive.
   
7. If you don’t find the rock before you activate the radar there are only 3 or 4 MPI, so it’s easy to find the rock after activation.
   

8A. Sneak your way to extraction and chill/hide. You shouldn’t have much time left until the extraction sequence.
8B. If you cleared the objectives, still let time expire and don’t active extraction. This auto-calls in Pelican 1 BUT doesn’t seem to trigger any major wave. I’m still testing but it’s been pretty consistent.
8C. You can drop the samples near the beacon in case you get killed but any adds should be manageable.

1. Hop on the bird and fly away with up to 6 super samples every 15 minutes or so.

I’ve done this as I said solo (and I’m not good) and with a group. I’ll usually sneak off looking for the radar or the rock while the rest of the team clears objectives and we just meet at extraction. Scout armor is probably the key.

Hi, I'm waiting for my 2nd assessment with CMagic, after having my first assessment back in November 2023.
It's a very long and convoluted story but basically I was led to believe that my second appointment would take place just a month or two after my first, and that I'd be able to access hormones by December 2023/January 2024.
The whole process is immensely frustrating and after being told that I'm probably waiting another 8-10 weeks until I can get hormones I was distraught and started self harming again.
I was told I couldn't book my second appointment until after the blood test results but I assumed it would only take a week or two so I was holding on, just to find out that it took 3 weeks for my GP to pass on the results to CMagic and that I now still have got a long wait.
I've only managed to cope so far because at every point I've been told that I only have to wait a few more weeks at each stage but since hearing that It will be a minimum of 6 weeks wait once i get the appointment, plus a few extra weeks of waiting for the appointment date, I've been feeling pretty desperate.
Today I went to my GP in Liverpool to ask about a bridging prescription. He said my surgery didn't do them and didn't think any surgery in Liverpool would. Has anyone had a positive experience of getting a bridging prescription in Liverpool?
If I go private for a prescription what/where do people recommend?
I've had gamete storage , had the blood test and have signed a consent form for my hormones through CMagic, so only really need a short term prescription to see me through until my 2nd assessment with CMagic.

My wife and I recently bought a house that is only 3 years old and after living in it for 1 month we suspect there is mold in the house. On the second floor the inspection report said that the wood floor was cupping but said we could fix that with a dehumidifier. We have since gotten a second opinion from a specialized mold inspector and he took samples and tests to confirm his suspicions that there is indeed mold present in our crawl space and most likely in the wall where the wood is cupping. This wall is the backside of the master bathroom vanity and most likely a line was pierced by a nail when installing the footer. Any advise on how to proceed would be much appreciated. The sellers did not disclose that there was a water leak, but there was a $0.00 line item on the address that home insurance picked up.
The first picture is of a home test we took to sample the air in the guest bathroom.
The second picture is of the home inspection detail about the cupping wood floor in the master.

My current role has several "milestones" that we have to meet for promotion. I quickly finished all but one milestone before my first annual review. The final milestone, which is a two-part skills assessment, I had to put off for months because my manager had the test under revision until a few weeks before my annual review. Once she released the tests, I took them. A colleague of mine who is level 2 in our role and has been there for 5 years also took these tests at the same time. We both failed the tests.
When I reviewed the things my manager marked incorrect, I checked with other team members, who all told me that they would have put the same answers I did on many of the "incorrect" questions. Several things that manager marked wrong, my teammates told me they've never heard of before and have never done as part of our regular work rotations.
The tests had no directions, other than a quick verbal explanation from my manager. We have no written guidelines, SOPs, or style standards to refer to. Meaning there's no definitive source of "truth" that I can point to to say that my manager's assessment was incorrect. Further, when discussing my results with her, she admitted that I found several things wrong in the tests that she didn't intend to have been in there. After my meeting to discuss the results, my manager immediately had another employee start writing new directions in all the areas I missed and pointed out to her.
Despite all of this, she still will not let me retake test until a one-month period has passed. This just so happens to fall a week after my annual review. Which means, for how our promotion structure works, even if I take and pass the tests after one month, I will have to wait another year for my second annual review to go up for promotion. My colleague who has been there for 5 years and also failed is in the same situation.
Is this a situation that I should escalate to either my manager's boss or HR? Is this a common thing to have happen at a job? Should I just start looking elsewhere and get out?

Prepare for the UGC NET Political Science Mock Test Free with India's Best Online Test Series based on the latest pattern. Get Free Mock Tests, Sample Papers, and Study Materials.

The global interactive whiteboard market is poised to experience substantial growth, with a projected compound annual growth rate (CAGR) of 7.5% during the forecast period to 2027, surpassing a value of USD 1.7 billion in 2020. This growth is fueled by several key factors, including the escalating adoption of digital learning and virtual classrooms on a global scale. Furthermore, the increasing demand for gamification techniques and the surging popularity of whiteboards integrated with artificial intelligence are anticipated to drive market expansion even further. The rapid proliferation of e-learning methodologies and the widespread uptake of virtual classrooms have contributed significantly to the market's upward trajectory.
To know more about this study, request a free sample report @ https://www.researchcorridor.com/request-sample/?id=4430
Market Trends:
Integration of Artificial Intelligence (AI): There's a growing trend towards integrating AI technologies into interactive whiteboards, enabling features such as intelligent content recommendation, real-time feedback, and personalized learning experiences. AI-powered whiteboards can analyze user interactions and adapt content dynamically, enhancing engagement and learning outcomes.
Rise of Hybrid Learning Environments: With the increasing adoption of hybrid learning models combining in-person and remote instruction, interactive whiteboards play a pivotal role in facilitating seamless collaboration and interaction between students and educators across physical and virtual spaces. Features like screen sharing, annotation tools, and remote access capabilities cater to the needs of both onsite and remote learners.
Focus on Remote Collaboration Tools: The shift towards remote work and virtual collaboration has accelerated the demand for interactive whiteboards with advanced remote collaboration features. These include cloud-based storage, video conferencing integrations, and multi-platform compatibility, enabling teams to collaborate effectively regardless of geographical location.
Gamification and Interactive Learning: Educational institutions and corporate training programs are increasingly incorporating gamification elements into interactive whiteboard solutions to enhance engagement and motivation. Gamified activities, quizzes, and interactive lessons not only make learning more enjoyable but also encourage active participation and knowledge retention.
Accessibility and Inclusivity Features: There's a growing emphasis on designing interactive whiteboards with accessibility features to cater to diverse learner needs. Features such as screen readers, color contrast adjustments, and voice commands enable inclusive learning experiences for students with disabilities or special educational requirements.
Market Opportunities:
The interactive whiteboard market presents numerous opportunities for growth and innovation. With the increasing adoption of digital learning solutions and remote collaboration tools, there is a significant opportunity for interactive whiteboard manufacturers to capitalize on the growing demand for advanced educational technologies. The rise of hybrid learning environments, driven by the shift towards blended learning models, creates a need for versatile interactive whiteboard solutions that seamlessly integrate in-person and virtual instruction. Moreover, the integration of artificial intelligence (AI) technologies presents opportunities to enhance interactive whiteboards with intelligent features such as personalized content recommendations and adaptive learning algorithms. Furthermore, the expanding market for corporate training and remote work solutions offers opportunities for interactive whiteboard vendors to cater to the needs of businesses seeking effective tools for virtual collaboration and communication.
According to the recent report published by RC Market Analytics, the Global Interactive Whiteboard Market is expected to provide sustainable growth opportunities during the forecast period from 2024 to 2030. This latest industry research study analyzes the interactive whiteboard market by various product segments, applications, regions and countries while assessing regional performances of numerous leading market participants. The report offers a holistic view of the interactive whiteboard industry encompassing numerous stakeholders including raw material suppliers, providers, distributors, consumers and government agencies, among others. Furthermore, the report includes detailed quantitative and qualitative analysis of the global market considering market history, product development, regional dynamics, competitive landscape, and key success factors (KSFs) in the industry.
Browse the Full Report Discretion @ https://www.researchcorridor.com/interactive-whiteboard-market/
Geographically, the interactive whiteboard market report comprises dedicated sections centering on the regional market revenue and trends. The interactive whiteboard market has been segmented on the basis of geographic regions into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Interactive whiteboard market estimates have also been provided for the historical years 2020 to 2023 along with forecast for the period from 2024 - 2030.The report includes a deep-dive analysis of key countries including the U.S., Canada, the U.K., Germany, France, Italy, China, Japan, India, Australia, Mexico, Brazil and South Africa, among others. Thereby, the report identifies unique growth opportunities across the world based on trends occurring in various developed and developing economies.
The Interactive Whiteboard Market Segmentation:
By Technology:

• Infrared
• Resistive Membrane
• Electromagnetic Pen
• Capacitive
• Others

By Form Factor:

• Fixed
• Portable

By Projection Technique:

• Front Projection
• Rear Projection

By Application:

• Education
• Corporate
• Commercial
• Others

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Prominent companies in the global interactive whiteboard market include Panasonic Corporation, LG Display Co., Ltd, Xiamen Interactive Technology Co., Ltd, SMART Technologies ULC, BenQ Corporation, and Cisco Systems, Inc. These firms are actively navigating market landscapes through various strategies such as expansion initiatives, fresh investments, service innovations, and collaborative ventures. Additionally, players are venturing into new geographical territories through expansion and acquisition endeavors, aiming to harness joint synergies for a competitive edge.
To know more about this study, request a free sample report @ https://www.researchcorridor.com/request-sample/?id=4430
Key Questions Answered by Interactive Whiteboard Market Report:

• Product popularity and adoption based on various country-level dynamics
• Regional presence and product development for leading market participants
• Market forecasts and trend analysis based on ongoing investments and economic growth in key countries
• Competitive landscape based on revenue, product offerings, years of presence, number of employees and market concentration, among others
• Various industry models such as SWOT analysis, Pestle Analysis, Porter’s Five Force model, Value Chain Analysis pertaining to Interactive Whiteboard market
• Analysis of the key factors driving and restraining the growth of the global, regional and country-level markets from 2020-2030

About Us:RC Market Analytics is a global market research firm. Our insightful analysis is focused on developed and emerging markets. We identify trends and forecast markets with a view to aid businesses identify market opportunities to optimize strategies. Our expert’s team of analysts’ provides enterprises with strategic insights. RC Market Analytics works to help enterprises grow through strategic insights and actionable solutions. Feel free to contact us for any report customization at sales@researchcorridor.com.
Media Contact:
Company Name: RC Market Analytics Pvt. Ltd. Contact Person: Vijendra Singh Email: sales@researchcorridor.com Visit us: https://www.researchcorridor.com/

i’m kinda discouraged because i took a self assessment on uworld and i scored “borderline” however i took 2 self-assessments on bootcamp and scored “very-high” & “high”. I test in 3 days and i am unsure if to move it back 1 week or not :/